- Home
- Publications
- Publication Search
- Publication Details
Title
Otelixizumab in the treatment of Type 1 diabetes mellitus
Authors
Keywords
-
Journal
Immunotherapy
Volume 3, Issue 11, Pages 1303-1316
Publisher
Future Medicine Ltd
Online
2011-11-05
DOI
10.2217/imt.11.123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arresting type 1 diabetes after diagnosis: GAD is not enough
- (2011) Chantal Mathieu et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
- (2011) Tom L. Van Belle et al. PHYSIOLOGICAL REVIEWS
- Humanizing Animal Models: A Key to Autoimmune Diabetes Treatment
- (2011) D. Bresson et al. Science Translational Medicine
- Human CD3 Transgenic Mice: Preclinical Testing of Antibodies Promoting Immune Tolerance
- (2011) C. Kuhn et al. Science Translational Medicine
- Caspase Inhibitor Therapy Synergizes With Costimulation Blockade to Promote Indefinite Islet Allograft Survival
- (2010) J. A. Emamaullee et al. DIABETES
- Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes
- (2010) P. Xu et al. DIABETES CARE
- Failure to Preserve -Cell Function With Mycophenolate Mofetil and Daclizumab Combined Therapy in Patients With New- Onset Type 1 Diabetes
- (2010) P. A. Gottlieb et al. DIABETES CARE
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes
- (2010) Stefanie Eising et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes
- (2010) Geoff Hale et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor–specified peripheral niche constraints
- (2010) Junko Nishio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients
- (2009) B. Keymeulen et al. BLOOD
- Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients
- (2009) E. Vandemeulebroucke et al. DIABETOLOGIA
- Pharmacokinetics and Pharmacodynamics of a Chimeric/Humanized Anti-CD3 Monoclonal Antibody, Otelixizumab (TRX4), in Subjects With Psoriasis and With Type 1 Diabetes Mellitus
- (2009) Paweł Wiczling et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study
- (2009) Christopher C Patterson et al. LANCET
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes
- (2008) M. D. Bellin et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Restoring a functional β-cell mass in diabetes
- (2008) D. Pipeleers et al. DIABETES OBESITY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started